Beacon Dermatology Inc /ID# 220940

Calgary, Alberta T3E 0B2

0 studies enrolling now · 1 studies all time

What they study most

Psoriasis

Studies at this site

• Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement — Completed